Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer

NCT01443377 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

BIOLOGICAL: Panitumumab

Sponsor

National Center for Tumor Diseases, Heidelberg